Idelalisib plus bendamustine and rituximab (BR) is superior to BR alone in patients with relapsed/refractory chronic lymphocytic leukemia: Results of a phase 3 randomized double-blind placebo-controlled study Meeting Abstract
| Authors: | Zelenetz, A.; Robak, T.; Coiffier, B.; Delgado, J.; Marlton, P.; Adewoye, A.; Kim, Y.; Dreiling, L.; Hillmen, P. |
| Abstract Title: | Idelalisib plus bendamustine and rituximab (BR) is superior to BR alone in patients with relapsed/refractory chronic lymphocytic leukemia: Results of a phase 3 randomized double-blind placebo-controlled study |
| Meeting Title: | 36th World Congress of the International Society of Hematology (ISH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 173 |
| Issue: | Suppl. |
| Meeting Dates: | 2016 Apr 18-21 |
| Meeting Location: | Glasglow, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2016-04-01 |
| Start Page: | 10 |
| Language: | English |
| ACCESSION: | WOS:000374543900011 |
| PROVIDER: | wos |
| PUBMED: | 27073127 |
| DOI: | 10.1111/bjh.14019 |
| Notes: | Meeting Abstract: 10 -- 36th World Congress of the International-Society-of-Hematology -- APR 18-21, 2016 -- British Soc Haematol, Glasgow, SCOTLAND -- Source: Wos |
